Genmab — Februar 2022
-
Genmab præsenterer foreløbige data for middel mod hoved- og halskræft https://www.proinvestor.com/investornyt/786724/genmab-praesenterer-forelobige-data-for-middel-mod-hoved-og-halskraeft
-
2102
-
Genmab præsenterer foreløbige data for middel mod hoved- og halskræft https://proinvestor.com/investornyt/786724/genmab-praesenterer-forelobige-data-for-middel-mod-hoved-og-halskraeft
-
OVERBLIK: Udvikling på finansielle markeder efter russisk angreb - NY4 https://proinvestor.com/investornyt/786752/overblik-udvikling-pa-finansielle-markeder-efter-russisk-angreb-ny4
-
Torsdagens aktier: Ørsted og Vestas trak C25 væk fra dybet https://proinvestor.com/investornyt/786797/torsdagens-aktier-orsted-og-vestas-trak-c25-vaek-fra-dybet
-
Pænt rebound fra bunden i 1946 til 2102
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind